Hepatitis C Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have a documented pregnancy, with the conception date confirmed either by the date of your last menstrual period or an ultrasound, and the actual delivery date on record.
- You must have a confirmed chronic Hepatitis C infection (HCV) that was diagnosed either before or during your pregnancy, shown by a positive blood test.
- You must have taken a specific type of Hepatitis C medication (called a direct-acting antiviral, or DAA) within 30 days of when you conceived and at some point before the end of your pregnancy (whether that ended in a live birth, miscarriage, or other outcome).
Who may not be able to join:
- If your Hepatitis C treatment included a medication called ribavirin or interferon, you would not be eligible, as these drugs are known to be harmful during pregnancy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: John Ward, MD, The Taskforce For Global Health
Phone: 4043014134
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of adverse pregnancy outcomes; Number of adverse birth outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.